logo BDSP

Base documentaire

  1. Improving drug use : a case study of events which led to changes in use of flucloxacillin in Australia.

    Article - En anglais

    Policy makers and health professionals charged with implementing policies to improve medication use require knowledge as to how to integrate and co-ordinate strategies and interventions which have been shown to be effective.

    Experimental methodologies are commonly used to assess the effectiveness of interventions to improve medication use and while valuable for determining the effectiveness of particular interventions, they do not add to our understanding of how to co-ordinate and integrate multiple initiatives to improve medication use.

    We argue that analyses of the overall system of events which are implemented to improve medication use are also needed.

    In this paper, we demonstrate how the case study analysed within the framework of the Transtheoretical Model of behaviour change can be used to provide an understanding of the relationship of events which result in changes in medication use.

    A case study of the sequence of events which led to changes in the utilisation of flucloxacillin in Australia is assessed.

    The analysis demonstrated that the effectiveness of individual interventions was dependent upon the initiatives which were implemented concurrently and those that had been implemented previously.

    Changes in the utilisation of flucloxacillin resulted from regulatory interventions and the promotion of appropriate alternative therapies. (...)

    Mots-clés Pascal : Flucloxacilline, Chimiothérapie, Traitement, Antibiotique, Antibactérien, Politique sanitaire, Australie, Océanie, Bactériose, Infection, Toxicité, Intervention, Hépatite, Homme, Pénicilline dérivé, bêta-Lactamines, Appareil digestif pathologie, Foie pathologie

    Mots-clés Pascal anglais : Flucloxacillin, Chemotherapy, Treatment, Antibiotic, Antibacterial agent, Health policy, Australia, Oceania, Bacteriosis, Infection, Toxicity, Operation, Hepatitis, Human, Penicillin derivatives, bêta-Lactams, Digestive diseases, Hepatic disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0171405

    Code Inist : 002B02S02. Création : 16/11/1999.